Detalhe da pesquisa
1.
Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program.
Antimicrob Agents Chemother
; 65(4)2021 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431416
2.
Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018).
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32015043
3.
Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
Antimicrob Agents Chemother
; 61(3)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28052853
4.
Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species.
Antimicrob Agents Chemother
; 61(8)2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533234
5.
Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
J Antimicrob Chemother
; 71(10): 2868-73, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27287236
6.
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Mycoses
; 58(4): 209-14, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25727853
7.
Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates.
Antimicrob Agents Chemother
; 58(1): 577-80, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24126582
8.
Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria.
J Clin Microbiol
; 52(1): 108-14, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24153129
9.
Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values.
Mycopathologia
; 178(1-2): 1-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24952015
10.
Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
Clin Infect Dis
; 56(12): 1724-32, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23487382
11.
In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods.
Antimicrob Agents Chemother
; 57(2): 1065-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23229479
12.
In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.
J Clin Microbiol
; 51(8): 2608-16, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23740727
13.
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
J Clin Microbiol
; 51(8): 2571-81, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23720791
14.
Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST).
J Antimicrob Chemother
; 68(4): 858-63, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23190764
15.
Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance programme.
Mycopathologia
; 174(4): 259-71, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22580756
16.
Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009.
Antimicrob Agents Chemother
; 55(2): 561-6, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21115790
17.
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
Antimicrob Agents Chemother
; 55(11): 5155-8, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21844312
18.
Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009).
J Clin Microbiol
; 49(1): 396-9, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21068282
19.
Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida.
J Clin Microbiol
; 49(11): 3800-4, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21900519
20.
Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods.
J Antimicrob Chemother
; 66(11): 2581-4, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21873291